Atle Fund Management AB Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001381843
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2024 · 38 positions · Total reported value $164.00M · Top-10 concentration 67.2% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 53.5% · 4 new · 15 cut · 4 exited
Active Share (vs S&P 500): 94.8% · vs QQQ: 98.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -10.0% · vs SPY -12.1% · Prev Value $371.70M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): +5.6% · vs SPY +3.4% · Latest Value $373.39M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q2 2024 13F filing, Atle Fund Management AB disclosed 38 equity positions with a combined reported value of $164.00M. The filing implies a focused portfolio: its ten largest positions account for 67.2% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q2 2024 were LLY ($24.58M), UNH ($16.13M), MRK ($13.96M). By sector, the heaviest allocations are Health Care 88.5%, Industrials 6.6%. Versus the prior quarter, allocation shifted toward Health Care (+3.1pp), Industrials (+1.2pp) and away from Other (-4.3pp).
Versus the prior quarter, Atle Fund Management AB opened 4 new positions, trimmed 15 and fully exited 4, a turnover rate of 53.5% of positions. The portfolio's overlap with the prior quarter was 74% of names.
The largest new positions opened in Q2 2024 were UFPT ($2.59M), ALKS ($1.66M), PHVS ($645.37K).
Of the 4 positions fully exited versus the prior quarter, the largest were ELV ($3.84M), GILD ($3.81M), FUSN ($2.96M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2024)
- UFPT UFP TECHNOLOGIES INC · $2.59M
- ALKS ALKERMES PLC · $1.66M
- PHVS PHARVARIS N V · $645.37K
Fully Exited (vs previous quarter)
- ELV ELEVANCE HEALTH INC FORMERLY · prev qtr: $3.84M
- GILD GILEAD SCIENCES INC · prev qtr: $3.81M · history
- FUSN FUSION PHARMACEUTICALS INC · prev qtr: $2.96M
- SWAV SHOCKWAVE MED INC · prev qtr: $1.55M
- EXAS EXACT SCIENCES CORP · prev qtr: $1.11M
- INSP INSPIRE MED SYS INC · prev qtr: $1.03M
- CYTK Cytokinetics, Incorporated · prev qtr: $981.54K
- MDGL MADRIGAL PHARMACEUTICALS INC · prev qtr: $945.05K
Insider Transactions (Form 4)
Latest Atle Fund Management AB buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Atle Fund Management AB files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 39 positions worth $371.70M in total. HoldingsHub carries 11 quarters of its filings (Q4 2023–Q2 2026).
Portfolio Structure
- 39 positions · $371.70M reported value (Q2 2026)
- Top 10 holdings = 48.0% of reported value
- Largest position: LLY (ELI LILLY & CO) at 9.6%
- Average position size: $9.53M
Sector Tilt
- Health Care 92.2%
- Consumer Staples 4.1%
- Industrials 3.8%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 3 new, 16 added, 20 reduced, 3 exited
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
27.14K | $24.58M | 14.98% | Add | |
| 2 |
|
31.68K | $16.13M | 9.84% | Add | |
| 3 |
|
112.73K | $13.96M | 8.51% | Reduce | |
| 4 |
|
19.46K | $10.76M | 6.56% | Add | |
| 5 |
|
27.59K | $8.62M | 5.26% | Add | |
| 6 |
|
106.56K | $8.21M | 5.00% | Add | |
| 7 |
|
6.89K | $7.24M | 4.42% | Add | |
| 8 |
|
15.10K | $7.08M | 4.31% | Add | |
| 9 |
|
30.32K | $6.83M | 4.17% | Add | |
| 10 |
|
19.98K | $6.80M | 4.15% | Add | |
| 11 |
|
35.62K | $6.11M | 3.73% | Add | |
| 12 |
|
34.48K | $3.91M | 2.38% | Add | |
| 13 |
|
36.51K | $3.37M | 2.06% | Add | |
| 14 |
|
23.63K | $3.25M | 1.98% | Reduce | |
| 15 |
|
13.98K | $2.96M | 1.80% | Add | |
| 16 |
|
9.50K | $2.82M | 1.72% | Reduce | |
| 17 |
|
27.50K | $2.70M | 1.65% | Hold | |
| 18 |
|
9.80K | $2.59M | 1.58% | New | |
| 19 |
|
75.20K | $2.57M | 1.57% | Reduce | |
| 20 |
|
35.84K | $2.45M | 1.50% | Reduce | |
| 21 |
|
40.69K | $1.94M | 1.18% | Reduce | |
| 22 |
|
30.84K | $1.82M | 1.11% | Add | |
| 23 |
|
39.10K | $1.77M | 1.08% | Add | |
| 24 |
|
68.80K | $1.66M | 1.01% | New | |
| 25 |
|
54.40K | $1.51M | 0.92% | Reduce | |
| 26 |
|
148.21K | $1.47M | 0.90% | Reduce | |
| 27 |
|
75.79K | $1.46M | 0.89% | Add | |
| 28 |
|
7.62K | $1.40M | 0.85% | Add | |
| 29 |
|
53.43K | $1.35M | 0.82% | Add | |
| 30 |
|
22.50K | $1.24M | 0.76% | Add | |
| 31 |
|
34.90K | $1.05M | 0.64% | Reduce | |
| 32 |
|
23.78K | $805.84K | 0.49% | Reduce | |
| 33 |
|
226.15K | $786.98K | 0.48% | Add | |
| 34 |
|
20.20K | $688.18K | 0.42% | Add | |
| 35 |
|
34.33K | $645.37K | 0.39% | New | |
| 36 |
|
143.41K | $609.48K | 0.37% | Add | |
| 37 |
|
64.32K | $481.12K | 0.29% | Reduce | |
| 38 |
|
184.90K | $371.65K | 0.23% | Add | |
FAQ
What did Atle Fund Management AB buy in 2024-Q2?
In its 2024-Q2 13F filing, Atle Fund Management AB reported 38 equity positions worth $164.00M in aggregate; its largest disclosed positions were LLY ($24.58M), UNH ($16.13M), MRK ($13.96M).
How large is Atle Fund Management AB's portfolio?
Atle Fund Management AB reported $164.00M of long equity holdings across 38 positions as of 2024-Q2. Top-10 holdings account for 67.2% of reported value.
What is Atle Fund Management AB's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.